Regeneron Stock Forecast & Price Target
Regeneron Price Target 2026
The Quantum Forecast sees a price target of $937.02 (+5.1%) for Regeneron in about one month (by Dec 10, 2026).
Quantum Forecast price targets by time frame, calculated from the current price of $891.38. Click to see the forecast in the chart.
Regeneron Forecast for Today and Tomorrow
In the short term, the Quantum Forecast sees Regeneron at $894.17 (+0.22%) today around 10 AM ET and at $887.56 (−0.52%) today around 3 PM ET. It is based on prices from the current trading day and the past week. Short-term forecast in the chart
Regeneron Stock 2026: Price Performance
Regeneron stock has gained 15.5% since the start of 2026 and currently trades at $891.38 (as of Nov 11, 2026). Over the same period the Nasdaq 100 is up 11.9%, putting the stock 3.5 percentage points ahead of the index. Over the past 52 weeks the price ranged between $592.21 and $997.02; it is currently 10.6% below its high of Nov 4, 2026.
Regeneron Forecast 2027
Over a horizon of roughly 10 months (until about Sep 2027), the Quantum Forecast sees a price target of $996.41 for Regeneron – +11.8% from today. The range band runs from $573.92 – $1,418.90: the further ahead the forecast looks, the greater the uncertainty. See the long-term forecast in the chart
Community Forecast for Regeneron
There are no user forecasts for Regeneron yet – be the first to make one.
Make your own forecastAbout Regeneron
Regeneron Pharmaceuticals is a biotechnology company headquartered in Tarrytown, New York. It was founded in 1988 by neurologist Leonard Schleifer. Regeneron focuses mainly on antibody medicines, built on its proprietary VelocImmune technology: genetically engineered mice that produce fully human antibodies.
Its most important in-house product is Eylea, injected into the eye to treat wet age-related macular degeneration and other retinal diseases. Together with Sanofi, Regeneron markets Dupixent for atopic dermatitis, asthma and other inflammatory conditions, and Libtayo is used in cancer treatment. Through the Regeneron Genetics Center, the company also runs a large collection of human genetic data for research. Customers include ophthalmologists, hospitals, specialists and health insurers, mainly in the United States; outside the U.S., partners such as Bayer market some of its drugs. Competition for Eylea, including from biosimilars, and the growth of Dupixent and pipeline results are central themes. Regeneron trades on the Nasdaq under the ticker REGN and is a member of the Nasdaq-100 and the S&P 500.
The current price of Regeneron stock is $891.38 (−2.67% vs. the previous close). In today's trading the high was $915.69 and the low $850.06.
How the Quantum Forecast works
Research from quantum physics. The models are the result of several years of research at the Max Planck Institute of Quantum Optics and LMU Munich and were transferred to the stock market.
Spectra and correlations. Frequency spectra are calculated from current prices, and the relationships between price swings and volatility are analyzed. This produces the forecast and the risk assessment.
Detecting herd behavior. Models of phase transitions from statistical physics describe when investors collectively fall into panic or euphoria – an early sign of possible crash situations.
Swarm intelligence. User forecasts are checked once their time frame has expired and feed into the model, weighted by their hit rate.
The range band shows the typical fluctuation around the forecast. More on quantum physics & swarm intelligence
Frequently Asked Questions about Regeneron Stock
What is the Regeneron stock forecast?
The Quantum Forecast expects Regeneron to reach $937.02 in about one month (by Dec 10, 2026), a change of +5.1% from the current price of $891.38. Over roughly 10 months (by Sep 2027) the price target is $996.41 (+11.8%).
What is the Regeneron stock price target?
Quantum Forecast price targets by time frame: 1 month $937.02 (+5.1%), 2 months $845.49 (−5.1%), 6 months $799.78 (−10.3%), 10 months $996.41 (+11.8%). The range band shows the typical fluctuation around these targets.
Will Regeneron stock go up or down?
In the short term the Quantum Forecast points up (+5.1% over one month). No forecast is certain – it is based on historical prices and statistical analysis.
How is the Quantum Forecast computed?
Trends, frequency spectra and correlations are calculated from the price history using methods from quantum physics; user opinions are added as well (swarm intelligence). The range band reflects the volatility of the security and widens with the time horizon.
Can I make my own forecast for Regeneron?
Yes – in the Forecast League you pick long or short and a price target for 1 day up to 6 months. Forecasts are scored automatically when they expire; correct calls earn points and a spot on the leaderboard.